Avalo Therapeutics’ (AVTX) Outperform Rating Reaffirmed at Wedbush
Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report issued on Thursday,RTT News reports. They currently have a $18.00 price objective on the stock. Wedbush’s price target indicates a potential upside of 134.99% from the stock’s current price. Wedbush also issued estimates for Avalo Therapeutics’ Q1 […]
Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report issued on Thursday,RTT News reports. They currently have a $18.00 price objective on the stock. Wedbush’s price target indicates a potential upside of 134.99% from the stock’s current price. Wedbush also issued estimates for Avalo Therapeutics’ Q1 […]
